Skip to main content
. 2011 Feb 24;6(2):e17142. doi: 10.1371/journal.pone.0017142

Table 1. Characteristics of the study populations.

ATBC CPS-II EPIC HPFS MCCS MEC PHS PLCO
Cases Controls Cases Controls Cases Controls Cases Controls Cases Controls Cases Controls Cases Controls Cases Controls
Number of Individuals 1,036 952 2,285 2,286 1,581 1,845 1,288 1,252 1,031 1,397 668 743 1,381 1,303 1,231 1,053
Mean 1 age (sd) 69.6(5.7) 69.0(5.7) 70.1(5.7) 70.2(5.7) 65.4(6.3) 65.4(6.3) 69.6(7.5) 67.6(7.6) 67.6(6.9) 54.4(8.8) 69.0(7.5) 70.4(7.3) 70.3(7.6) 70.2(7.6) 67.0(5.5) 69.0(5.7)
≤65 years (%) 259(25) 263(28) 470(21) 484(21) 806(51) 946(51) 357(28) 458(37) 378(37) 1,211(87) 206(31) 199(27) 377(27) 369(28) 470(38) 289(27)
>65 years (%) 777(75) 689(72) 1,815(79) 1,802(79) 775(49) 899(49) 931(72) 794(63) 653(63) 186(13) 462(69) 544(73) 1,004(73) 934(72) 761(62) 764(73)
FH + (%) 56(3) 29(3) 494(22) 300(13) NA NA 201(16) 143(11) 118(11) 99(7) 76(11) 59(8) NA NA 143(12) 62(6)
Missing (%) 134(13) 114(12) 0 (0) 0 (0) 1,581(100) 1,845(100) 0 (0) 0(0) 313(30) 373(27) 37(6) 36(5) 1,303(100) 1,303(!00) 37(3) 16(2)
BMI (%)
<25 395(38) 364(38) 893(40) 821(36) 517(33) 582(32) 524(47) 505(46) 272(26) 412(29) 244(37) 265(36) 798(58) 769(59) 327(27) 259(25)
25–30 504(49) 449(47) 1,118(50) 1,149(51) 846(54) 953(52) 497(44) 475(43) 581(56) 748(54) 328(49) 361(49) 541(39) 490(38) 631(52) 535(51)
>30 137(13) 138(15) 247(10) 285(13) 218(14) 310(17) 100(9) 116(11) 178(17) 237(17) 96(14) 116(16) 42(3) 44(3) 258(21) 249(24)
Missing (%) 0(0) 1(0) 27(1) 31(1) 0(0) 0(0) 167(13) 156(12) 0(0) 0(0) 0(0) 1(0) 0(0) 0(0) 15(1) 10(1)
Height (%)
<173 cm 493(52) 486(47) 532(22) 542(25) 826(49) 808(46) 293(28) 322(25) 678(56) 606(50) 238(35) 211(29) 275(22) 338(24) 283(25) 290(26)
173180 cm 342(36) 405(39) 633(26) 652(30) 613(36) 646(37) 387(37) 632(49) 399(33) 399(33) 167(25) 216(29) 504(40) 651(46) 346(30) 332(29)
>180 cm 120(12) 141(14) 1,227(52) 952(45) 246(15) 287(17) 371(35) 348(24) 141(11) 205(17) 269(40) 309(42) 475(38) 441(30) 510(45) 506(45)
Missing (%) 0(0) 1(0) 21(1) 12(1) 0(0) 0(0) 101(8) 86(7) 0(0) 0(0) 0(0) 1(0) 0(0) 0(0) 11(1) 6(1)
Smoking (%)
Never 0(0) 0(0) 816 (36) 838 (37) 547 (35) 622 (34) 605(48) 532(44) 444(43) 608(44) 233(35) 249(34) 671(49) 658(50) 507(41) 395(38)
Former 0(0) 0(0) 661 (58) 1,330 (59) 661(42) 753(41) 593(47) 638(52) 499(48) 594(43) 364(55) 406(55) 589(43) 544(42) 627(51) 541(51)
Current 1,036(100) 952(100) 348(6) 105(5) 348(22) 443(24) 56(4) 49(4) 88(9) 195(14) 66(10) 84(11) 119(9) 101(8) 96(8) 117(11)
Missing (%) 0(0) 0(0) 17(1) 13(1) 25(2) 27(1) 34(3) 33(3) 0(0) 0(0) 5(1) 4(1) 2(0) 0(0) 1(0) 0(0)
Alcohol Consumption (%)
<30 g/day 816(79) 740(78) 1,867(82) 1,890(84) 1,206(76) 1,443(78) 1,106(86) 1,070(85) 757(73) 1,030(74) 484(70) 560(75) 1,375(100) 1,293(99) 945(77) 816(77)
≥30 g/day 176(17) 165(17) 291(13) 247(11) 375(24) 402(22) 143(11) 135(11) 272(26) 367(26) 162(24) 152(20) 0(0) 0(0) 203(16) 167(16)
Missing (%) 44(4) 47 (5) 127 (5) 149 (5) 0(0) 0(0) 39 (3) 47(4) 2(1) 0(0) 22(6) 31(5) 6(0) 10(1) 83(7) 70(7)
Diabetes (%) 34 (3) 24 (3) 100 (4) 150 (7) 66 (5) 95 (6) 67 (5) 59 (5) 34 (3) 51 (4) 25 (4) 38 (5) 21 (2) 19 (1) 82 (7) 117 (11)
Missing (%) 0(0) 0(0) 0(0) 0(0) 279(18) 357(18) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 2(0) 1(0) 34(3) 34(3)
High Grade 2 (%) 199(19) NA 323(14) NA 75(5) NA 114(9) NA 148(14) NA 206(30) NA 197(14) NA 126(10) NA
Missing (%) 174(!7) NA 326(1$) NA 780(49) NA 190(15) NA 27(3) NA 28(4) NA 38(3) NA 2(0) NA
High Stage 3 (%) 258(25) NA 409(18) NA 257(16) NA 139(11) NA 93(9) NA 85(11) NA 231(17) NA 245(20) NA
Missing (%) 205(20) NA 65(3) NA 506(32) NA 197(15) NA 34(3) NA 15(2) NA 572(41) NA 0(0) NA
1

Age is calculated at age of diagnosis/selection as control except for MCCS (at baseline for controls) and MEC (at blood draw for controls).

2

Defined as Gleason 8–10 or WHO grade III.

3

Defined as Stage CD.